Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8896 |
High Similarity |
NPD6959 |
Discontinued |
0.8844 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8844 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8816 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8627 |
High Similarity |
NPD7819 |
Suspended |
0.8627 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8621 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8621 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD1549 |
Phase 2 |
0.8552 |
High Similarity |
NPD6099 |
Approved |
0.8552 |
High Similarity |
NPD6100 |
Approved |
0.8503 |
High Similarity |
NPD2800 |
Approved |
0.8497 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8435 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8356 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8345 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8344 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8344 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8323 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8322 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8299 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8278 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8269 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8224 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8224 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8224 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8219 |
Intermediate Similarity |
NPD6651 |
Approved |
0.82 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.817 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8165 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8153 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8148 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8148 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8113 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8108 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8089 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8039 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7962 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7945 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7925 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7922 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7898 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7895 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7895 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7892 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7881 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7844 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7832 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7826 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7815 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7811 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7798 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7764 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7751 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7751 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7703 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7658 |
Intermediate Similarity |
NPD920 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7588 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7574 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7569 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7562 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD2798 |
Approved |
0.755 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.755 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7532 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD943 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7458 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7457 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7439 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7421 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7421 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7397 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7389 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7346 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7345 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7337 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7329 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7308 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7305 |
Intermediate Similarity |
NPD919 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2403 |
Approved |
0.729 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7237 |
Intermediate Similarity |
NPD411 |
Approved |
0.7237 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7209 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD17 |
Approved |
0.7181 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7179 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7162 |
Intermediate Similarity |
NPD3972 |
Approved |
0.716 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7108 |
Intermediate Similarity |
NPD37 |
Approved |
0.7104 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7097 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7091 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7081 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7067 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7032 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7024 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7021 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.702
|
Intermediate Similarity |
NPD1164 |
Approved |